Immunotherapy in Epidermal Growth Factor Receptor-mutant 
Non-small Cell Lung Cancer

Immunotherapy in Epidermal Growth Factor Receptor-mutant 
Non-small Cell Lung Cancer

Targeted therapy and immunotherapy are important treatments for non-small cell lung cancer (NSCLC). At present, the clinical and basic research of epidermal growth factor receptor (EGFR) mutation NSCLC is still in the exploratory stage, needing to optimize the efficacy, combination, sequence and dos...

Full description

Bibliographic Details
Main Authors: Xin WANG, Diansheng ZHONG
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2019-08-01
Series:Chinese Journal of Lung Cancer
Subjects:
Lung neoplasms
Epidermal growth factor receptor
Immunotherapy
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2019.08.11

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2019.08.11

Similar Items